Oct 1 (Reuters) - The European Medicines Agency said on
Tuesday that it has withdrawn the marketing authorisation for
Abbvie's ( ABBV ) hepatitis C drug Exviera at the request of the
company.
The regulator said it withdrew authorisation for the drug on
Sept. 25.